Switching on the green light for chimeric antigen receptor T‐cell therapy

Adoptive cellular therapy involving genetic modification of T cells with chimeric antigen receptor (CAR) transgene offers a promising strategy to broaden the efficacy of this approach for the effective treatment of cancer. Although remarkable antitumor responses have been observed following CAR T‐ce...

Descripción completa

Detalles Bibliográficos
Autores principales: Mardiana, Sherly, Lai, Junyun, House, Imran Geoffrey, Beavis, Paul Andrew, Darcy, Phillip Kevin
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2019
Materias:
Special Feature Reviews
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500780/
https://www.ncbi.nlm.nih.gov/pubmed/31073403
http://dx.doi.org/10.1002/cti2.1046

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6500780/
https://www.ncbi.nlm.nih.gov/pubmed/31073403
http://dx.doi.org/10.1002/cti2.1046

Ejemplares similares